Aspen Pharmacare Holdings Ltd
JSE:APN
Intrinsic Value
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of APN.
Fundamental Analysis
Balance Sheet Decomposition
Aspen Pharmacare Holdings Ltd
| Current Assets | 44B |
| Cash & Short-Term Investments | 11.6B |
| Receivables | 13.5B |
| Other Current Assets | 19B |
| Non-Current Assets | 95.3B |
| PP&E | 19.6B |
| Intangibles | 73.6B |
| Other Non-Current Assets | 2B |
| Current Liabilities | 22.9B |
| Accounts Payable | 10.6B |
| Other Current Liabilities | 12.4B |
| Non-Current Liabilities | 30.7B |
| Long-Term Debt | 24.5B |
| Other Non-Current Liabilities | 6.2B |
Earnings Waterfall
Aspen Pharmacare Holdings Ltd
|
Revenue
|
42.7B
ZAR
|
|
Cost of Revenue
|
-23.4B
ZAR
|
|
Gross Profit
|
19.3B
ZAR
|
|
Operating Expenses
|
-11.9B
ZAR
|
|
Operating Income
|
7.4B
ZAR
|
|
Other Expenses
|
-2.6B
ZAR
|
|
Net Income
|
4.9B
ZAR
|
Free Cash Flow Analysis
Aspen Pharmacare Holdings Ltd
What is Free Cash Flow?
APN Profitability Score
Profitability Due Diligence
Aspen Pharmacare Holdings Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Aspen Pharmacare Holdings Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
APN Solvency Score
Solvency Due Diligence
Aspen Pharmacare Holdings Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Aspen Pharmacare Holdings Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
APN Price Targets Summary
Aspen Pharmacare Holdings Ltd
Shareholder Return
APN Price
Aspen Pharmacare Holdings Ltd
| Average Annual Return | 14.2% |
| Standard Deviation of Annual Returns | 47.27% |
| Max Drawdown | -52% |
| Market Capitalization | 96.6B Zac |
| Shares Outstanding | 4 449 656 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. The company is headquartered in Durban, Kwazulu-Natal and currently employs 8,581 full-time employees. The firm is focused on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through its key business segments: Manufacturing and Commercial Pharmaceuticals. The Manufacturing segment relates to the manufacture and sale of APIs and finished dose form products to third-party customers. Its Commercial Pharmaceuticals segment comprises Regional Brands and Sterile Focus Brands that include Anaesthetics and Thrombosis products. The company operates approximately 23 manufacturing facilities on six continents. Its manufacturing capabilities cover a wide variety of product types including orals, liquids, steriles, biologicals and APIs.
You don't have any saved screeners yet
